Michael Smith - Ingevity Corp President
| NGVT Stock | USD 42.38 0.76 1.76% |
President
Mr. Michael P. Smith serves as Executive Vice President and President, Performance Chemicals, Strategy and Business Development of the Company. Mr. Smith joined Ingevity in June 2016 after 23 years of service at FMC Corporationrationration. He served as Vice President and Global Business Director for FMCs Health and Nutrition business after holding multiple positions of increasing responsibility within that business. During his career with the company, Mr. Smith held various roles including Marketing Manager for FMC Water Treatment Chemicals in Manchester, England Global Business Manager for FMC Process Additives, also in Manchester Director of Business Planning for FMC Chemicals Division General Manager for the Active Oxidants division Division General Manager for Hydrogen Peroxide General Manager for Food Ingredients for FMC BioPolymer and Division General Manager for FMC BioPolymer. Prior to joining FMC, Mr. Smith held several sales and management positions with Hercules Incorporated, a supplier of hydrocarbon and pinebased resins
| Age | 59 |
| Professional Marks | MBA |
| Address | 4920 O'Hear Avenue, North Charleston, SC, United States, 29405 |
| Phone | 843 740 2300 |
| Web | https://www.ingevity.com |
Michael Smith Latest Insider Activity
Tracking and analyzing the buying and selling activities of Michael Smith against Ingevity Corp stock is an integral part of due diligence when investing in Ingevity Corp. Michael Smith insider activity provides valuable insight into whether Ingevity Corp is net buyers or sellers over its current business cycle. Note, Ingevity Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell Ingevity Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Michael Smith over a week ago Disposition of 10 shares by Michael Smith of V2X subject to Rule 16b-3 | ||
Michael Smith over a month ago Acquisition by Michael Smith of 20764 shares of McCormick Company subject to Rule 16b-3 | ||
Michael Smith over three months ago Disposition of 11900 shares by Michael Smith of Insmed at 17.16 subject to Rule 16b-3 | ||
Michael Smith over three months ago Disposition of 834 shares by Michael Smith of ICC Holdings subject to Rule 16b-3 |
Ingevity Corp Management Efficiency
The company has return on total asset (ROA) of 0.0717 % which means that it generated a profit of $0.0717 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0411) %, meaning that it created substantial loss on money invested by shareholders. Ingevity Corp's management efficiency ratios could be used to measure how well Ingevity Corp manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to gain to 0.23 in 2025, despite the fact that Return On Tangible Assets are likely to grow to (0.26). Change To Liabilities is likely to gain to about 51.6 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 225 M in 2025.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Adrian Steeples | Quaker Chemical | 60 | |
| David Slinkman | Quaker Chemical | 60 | |
| Thomas Meek | Minerals Technologies | 67 | |
| Paul Whittleston | Ecovyst | 50 | |
| Lixing Min | Orion Engineered Carbons | 59 | |
| Pedro Riveros | Orion Engineered Carbons | 54 | |
| Joseph Berquist | Quaker Chemical | 54 | |
| Michael Geraghty | Sensient Technologies | 63 | |
| Paula Cooney | H B Fuller | 50 | |
| Matthew Garth | Minerals Technologies | 46 | |
| Andrew Jones | Minerals Technologies | 61 | |
| Carlos Quinones | Orion Engineered Carbons | 59 | |
| Wilbert Platzer | Quaker Chemical | 63 | |
| John Corkrean | H B Fuller | 59 | |
| Zhiwei Cai | H B Fuller | 62 | |
| Steve Morris | Sensient Technologies | 61 | |
| Brett Argirakis | Minerals Technologies | 60 | |
| Michael Feehan | Ecovyst | 48 | |
| David Jones | Innospec | 55 | |
| Timothy Keenan | H B Fuller | 66 | |
| Jessica Moskowitz | Oil Dri | 41 | |
Management Performance
| Return On Equity | -1.04 | ||||
| Return On Asset | 0.0717 |
Ingevity Corp Leadership Team
Elected by the shareholders, the Ingevity Corp's board of directors comprises two types of representatives: Ingevity Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Ingevity. The board's role is to monitor Ingevity Corp's management team and ensure that shareholders' interests are well served. Ingevity Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Ingevity Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
| J Fitzpatrick, Independent Director | ||
| John Nypaver, VP Relations | ||
| Phillip Platt, Senior Officer | ||
| John Fortson, President, Chief Executive Officer, Interim Chief Financial Officer, Treasurer, Director | ||
| Mary Hall, Chief Financial Officer, Executive Vice President, Treasurer | ||
| Frederick Lynch, Lead Independent Director | ||
| Luis FernandezMoreno, Independent Director | ||
| Richard White, Senior Chemicals | ||
| Michael Smith, Executive Vice President and President Performance Chemicals, Strategy and Business Development | ||
| Diane Gulyas, Independent Director | ||
| Erik Ripple, VP Officer | ||
| S Woodcock, Executive Vice President and President - Performance Materials | ||
| Steve Hulme, Senior Vice President - Performance Chemicals, and President Engineered Polymers | ||
| Stacy Cozad, Executive Vice President General Counsel, Company Secretary | ||
| Stuart Woodcock, Executive Materials | ||
| Daniel Sansone, Independent Director | ||
| Christine Stunyo, Senior Officer | ||
| Jean Blackwell, Independent Chairman of the Board | ||
| Ryan Fisher, Vice President, Deputy General Counsel | ||
| Karen Narwold, Independent Director | ||
| Rich White, Senior Vice President - Performance Chemicals, and President Industrial Specialties and Pavement Technologies | ||
| Caroline Monahan, Director Communications | ||
| Terrance Dyer, Senior Officer | ||
| Daniel Gallagher, VP Relations | ||
| Steven Hulme, Senior Technologies |
Ingevity Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Ingevity Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.04 | ||||
| Return On Asset | 0.0717 | ||||
| Profit Margin | (0.31) % | ||||
| Operating Margin | 0.21 % | ||||
| Current Valuation | 2.95 B | ||||
| Shares Outstanding | 36.35 M | ||||
| Shares Owned By Insiders | 0.93 % | ||||
| Shares Owned By Institutions | 99.07 % | ||||
| Number Of Shares Shorted | 1.15 M | ||||
| Price To Earning | 16.90 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Ingevity Stock Analysis
When running Ingevity Corp's price analysis, check to measure Ingevity Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ingevity Corp is operating at the current time. Most of Ingevity Corp's value examination focuses on studying past and present price action to predict the probability of Ingevity Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ingevity Corp's price. Additionally, you may evaluate how the addition of Ingevity Corp to your portfolios can decrease your overall portfolio volatility.